Table 1.
T-LGL Leukemia Cohort | Splenomegaly | No Splenomegaly | p-Value |
---|---|---|---|
Total Number in Cohort (Female) | 34 (16) | 22 (8) | 0.61 |
Median Age at Diagnosis in Years (Range) | 64 (28–81) | 64 (31–78) | 0.88 |
Single Lineage Cytopenia | 10/34 (29%) | 15/22 (68%) | <0.01 |
Anemia (Hgb<10g/dL) | 8/34 (24%) | 9/22 (41%) | 0.17 |
Neutropenia | 1/34 (3%) | 5/22 (23%) | 0.02 |
Thrombocytopenia | 1/34 (3%) | 1/22 (5%) | 0.75 |
Bicytopenia | 16/34 (47%) | 3/22 (14%) | <0.01 |
Pancytopenia | 8/34 (24%) | 3/22 (14%) | 0.36 |
Median LGL Count (Range) | 1800 (100–20575) | 1130 (100–7410) | 0.41 |
Median CD4:CD8 (Range) | 0.35 (0.03–3.00) | 0.31 (0.04–1.39) | 0.51 |
Median % Vβ expansion (Range) | 63 (19–98) | 64 (11–90) | 0.88 |
Splenomegaly was identified by palpation or clinical suspicion and confirmed by ultrasound or CT scan.